Abstract: A silicone-polyolefin composition is disclosed. The silicone-polyolefin composition comprises (A) a polysiloxane, (B) a functionalized polyolefin, and (C) a curable silicone elastomer component. The polysiloxane (A) comprises an average of at least one functional group X per molecule, and the functionalized polyolefin (B) comprises an average of at least one functional group Y per molecule, where the functional group X and functional group Y are reactable to form a bond therebetween. A silicone-polyolefin blend, a curable composition comprising the silicone-polyolefin blend, a cured product of the curable composition, and methods of preparing the silicone-polyolefin blend, curable composition, and cured product are also disclosed.

Abstract: A flowable silicone-polyolefin composition is disclosed. The silicone-polyolefin composition comprises (A) a polysiloxane and (B) a functionalized polyolefin dispersed in the polysiloxane (A). The polysiloxane (A) comprises an average per molecule of at least one functional group X, and the functionalized polyolefin (B) comprises an average per molecule of at least one functional group Y that is reactable with the functional group X of the polysiloxane (A) to form a bond therebetween. A curable composition comprising the flowable silicone-polyolefin composition, a cured product of the curable composition, and methods of preparing the flowable silicone-polyolefin composition, curable composition, and cured product are also disclosed.

Abstract: Disclosed herein are glass pharmaceutical vials having sidewalls of reduced thickness. In embodiments, the glass pharmaceutical vial may include a glass body comprising a sidewall enclosing an interior volume. An outer diameter D of the glass body is equal to a diameter d1 of a glass vial of size X as defined by ISO 8362-1, wherein X is one of 2R, 3R, 4R, 6R, 8R, 10R, 15R, 20R, 25R, 30R, 50R, and 100R as defined by ISO 8362-1. However, the sidewall of the glass pharmaceutical vial comprises an average wall thickness Ti that is less than or equal to 0.85*s1, wherein s1 is a wall thickness of the glass vial of size X as defined by ISO 8362-1 and X is one of 2R, 3R, 4R, 6R, 8R, 10R, 15R, 20R, 25R, 30R, 50R, and 100R as defined by ISO 8362-1.

Abstract: Disclosed herein are glass pharmaceutical vials having sidewalls of reduced thickness. In embodiments, the glass pharmaceutical vial may include a glass body comprising a sidewall enclosing an interior volume. An outer diameter D of the glass body is equal to a diameter d1 of a glass vial of size X as defined by ISO 8362-1, wherein X is one of 2R, 3R, 4R, 6R, 8R, 10R, 15R, 20R, 25R, 30R, 50R, and 100R as defined by ISO 8362-1. However, the sidewall of the glass pharmaceutical vial comprises an average wall thickness Ti that is less than or equal to 0.85*s1, wherein s1 is a wall thickness of the glass vial of size X as defined by ISO 8362-1 and X is one of 2R, 3R, 4R, 6R, 8R, 10R, 15R, 20R, 25R, 30R, 50R, and 100R as defined by ISO 8362-1.

Abstract: Compositions and methods relating to partially hydrolyzed fucoidan for use in dietary supplements and skin-care products are described. Fucoidan from brown seaweeds is partially hydrolyzed and/or sulfonated and then mixed with other ingredients for use as a dietary supplement in beverage, capsule, or tablet form or for use as a skin-care product. Other ingredients that can be included in the dietary supplements include vitamins, minerals, amino acids, carotenoids, flavonoids, antioxidants, aminosugars, glycosaminoglycans, and botanicals. Skin care products according to the present invention comprise partially hydrolyzed fucoidan and a base.

Abstract: A sports drink concentrate, comprising a composition of partially hydrolyzed fucoidan, a carbohydrate, an electrolyte, and water. The composition may be in a concentrated form and diluted before consumption.

Abstract: Dietary supplements include a complementary blend of fruits including at least noni and Luo Han Guo. Other fruits having a high ORAC value, such as blueberries and raspberries, are also preferably incorporated. The combination of the Luo Han Guo and noni masks the noni's flavors and odors while sweetening the dietary supplements. The Luo Han Guo can be simultaneously provided in both powder and liquid form so that the liquid form acts as the primary sweetener while the powder form acts as the primary masker. The dietary supplements also have an enhanced natural preservative effect, providing an extended shelf life without the use of artificial preservatives.

Abstract: Compositions and methods relating to partially hydrolyzed fucoidan for use in skin care compositions are described. Fucoidan from brown seaweeds is partially hydrolyzed and then mixed with other ingredients for use as a skin care composition in cream, lotion, ointment, or other form. The fucoidan is partially hydrolyzed with acid and heat. The partially hydrolyzed fucoidan may also be sulfonated. Other ingredients that may be included in the skin care composition include fragrances, proteins, colorants or coloring agents, lipids, vitamins, botanical extracts, lipids, glycolipids, polymers, and copolymers, and the like.

Abstract: Compositions and methods relating to partially hydrolyzed fucoidan for use in dietary supplements are described. Fucoidan from brown seaweeds is partially hydrolyzed and then mixed with other ingredients for use as a dietary supplement in beverage, capsule, or tablet form. The fucoidan is partially hydrolyzed with acid and heat. The partially hydrolyzed fucoidan can also be sulfonated. Other ingredients that can be included in the dietary supplement include high-ORAC-value antioxidants, minerals, pepper extract, flavoring agents, coloring agents, and preservatives. The compositions can be in the form of beverages, tablets, capsules, powders, and the like.

Abstract: A dehydrated sports drink powder, comprising a solution of partially hydrolyzed fucoidan, a carbohydrate, and an electrolyte. According to another embodiment is a sports drink which includes a solution of the dehydrated sports drink powder and water.

Abstract: Compositions and methods relating to partially hydrolyzed fucoidan for use in dietary supplements are described. Fucoidan from brown seaweeds is partially hydrolyzed and then mixed with other ingredients for use as a dietary supplement in beverage, capsule, or tablet form. The fucoidan is partially hydrolyzed with acid and heat. The partially hydrolyzed fucoidan can also be sulfonated. Other ingredients that can be included in the dietary supplement include high-ORAC-value antioxidants, minerals, pepper extract, flavoring agents, coloring agents, and preservatives. The compositions can be in the form of beverages, tablets, capsules, powders, and the like.

Abstract: A hair treatment composition for topical application to the skin and/or hair, comprising partially hydrolyzed fucoidan and a pharmaceutical carrier. The composition may contain further additives. The carrier may be hydrophyllic or anhydrous. The composition may also include natural components such as honey and/or mangosteen. The composition may also include flavonoids, analgesics, radiation protecting agents, and/or anti-oxidants.

Abstract: A composition for skin protection from ultraviolet damage and for application to skin or hair, including partially hydrolyzed fucoidan, a base, and a radiation protecting agent. The partially hydrolyzed fucoidan may be fucoidan derived from Tongan limu moui seaweed, Japanese kombu seaweed, Japanese mozuku seaweed, or combinations thereof.

Abstract: An infant formula composition including fucoidan, a protein, and a lipid. The fucoidan may be partially hydrolyzed, and also may be sulfonated. The protein may be derived from quinoa. Also disclosed are infant formula kits to be assembled in the field. The kits may include a substantially dehydrated infant formula composition and a diluting agent. The kit may alternatively include a ready-to-consume infant formula composition and substantially dehydrated additives which may be added to the formula before consumption.

Abstract: A skin care article including a carrier and a moist application that includes partially hydrolyzed fucoidan. The partially hydrolyzed fucoidan may by sulfonated. The present invention also discloses a method of making a skin care article by partially hydrolyzing fucoidan, mixing it with a base and applying it to a carrier. The carrier may be flushable.

Abstract: Methods of making partially hydrolyzed fucoidan. Fucoidan from brown seaweeds is partially hydrolyzed and then mixed with other ingredients for use as a dietary supplement in beverage, capsule, or tablet form. The fucoidan is partially hydrolyzed with acid and heat. The partially hydrolyzed fucoidan can also be sulfonated. Other ingredients that can be included in the dietary supplement include high-ORAC-value antioxidants, minerals, pepper extract, flavoring agents, coloring agents, and preservatives. The compositions can be in the form of beverages, tablets, capsules, powders, and the like.

Abstract: Skin care compositions for the care of wrinkles including partially hydrolyzed fucoidan, a base, and an anti-wrinkle compound. The partially hydrolyzed fucoidan may be sulfonated. The partially hydrolyzed fucoidan may be derived from Japanese mozuku seaweed, Japanese kombu seaweed, or Tongan limu moui seaweed. Also disclosed is a method of making the skin care composition.

Abstract: A baby food composition for consumption by, and to provide nutrition to a baby, which includes partially hydrolyzed fucoidan. The fucoidan may be sulfonated. The baby food composition may be in the form of a prepared food, a drink, a hard finger food, a soft finger food, or a cereal.

Abstract: An article with skin-protecting and moisturizing compound, comprising a tissue substrate, a base and partially hydrolyzed fucoidan. The partially hydrolyzed fucoidan may be sulfonated. The partially hydrolyzed fucoidan may be derived from Tongan limu moui seaweed, Japanese wakame seaweed, Japanese mozuku seaweed, or combinations thereof.

Abstract: Liquid dietary supplements include vitamins, macro minerals, trace minerals, high Oxygen Radical Absorption Capacity (ORAC) compounds, and optionally fulvates. Despite the tendency of minerals in such a liquid mineral and vitamin supplement to precipitate and for the ingredients to quickly degrade, particularly at high ORAC values and low pH, embodiments of the invention stay in solution have a desired shelf life without degrading. In part, this is achieved through the use of the natural preservative momordica, carefully formulated amounts of the various ingredients, and high-tech processing.